Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Collins, RH' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 32 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Weinberg, K; Blazar, BR; Wagner, JE; Agura, E; Hill, BJ; Smogorzewska, M; Koup, RA; Betts, MR; Collins, RH; Douek, DC
      Factors affecting thymic function after allogeneic hematopoietic stem celltransplantation

      BLOOD
    2. Malik, AH; Collins, RH; Saboorian, MH; Lee, WM
      Chronic graft-versus-host disease after hematopoietic cell transplantationpresenting as an acute hepatitis

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    3. Gatlin, J; Douglas, J; Evans, JT; Collins, RH; Wendel, GD; Garcia, V
      In vitro selection of lentivirus vector-transduced human CD34(+) cells

      HUMAN GENE THERAPY
    4. Collins, RH; Goldstein, S; Giralt, S; Levine, J; Porter, D; Drobyski, W; Barrett, J; Johnson, M; Kirk, A; Horowitz, M; Parker, P
      Donor leukocyte infusions in acute lymphocytic leukemia

      BONE MARROW TRANSPLANTATION
    5. Salama, M; Nevill, T; Marcellus, D; Parker, P; Johnson, M; Kirk, A; Porter, D; Giralt, S; Levine, JE; Drobyski, W; Barrett, AJ; Horowitz, M; Collins, RH
      Donor leukocyte infusions for multiple myeloma

      BONE MARROW TRANSPLANTATION
    6. Douek, DC; Vescio, RA; Betts, MR; Brenchley, JM; Hill, BJ; Zhang, L; Berenson, JR; Collins, RH; Koup, RA
      Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution

      LANCET
    7. Porter, DL; Collins, RH; Hardy, C; Kernan, NA; Drobyski, WR; Giralt, S; Flowers, MED; Casper, J; Leahey, A; Parker, P; Mick, R; Bate-Boyle, B; King, R; Antin, JH
      Treatment of relapsed leukemia after unrelated donor marrow transplantation with unrelated donor leukocyte infusions

      BLOOD
    8. Fleming, DR; Wolff, SN; Fay, JW; Brown, RA; Lynch, JP; Bolwell, BJ; Stevens, DA; Goodman, SA; Greer, JP; Stein, RS; Pineiro, LA; Collins, RH; Goldsmith, LJ; Herzig, GP; Herzig, RH
      Protracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the north American marrow transplant group

      LEUKEMIA & LYMPHOMA
    9. COLLINS RH; PINEIRO LA; AGURA ED; FAY JW
      TREATMENT OF T-PROLYMPHOCYTIC LEUKEMIA WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Bone marrow transplantation
    10. COLLINS RH; SHPILBERG O; DROBYSKI WR; PORTER DL; GIRALT S; CHAMPLIN R; GOODMAN SA; WOLFF SN; HU W; VERFAILLIE C; LIST A; DALTON W; OGNOSKIE N; CHETRIT A; ANTIN JH; NEMUNAITIS J
      DONOR LEUKOCYTE INFUSIONS IN 140 PATIENTS WITH RELAPSED MALIGNANCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Journal of clinical oncology
    11. COLLINS RH; SACKLER M; PITCHER CJ; WALDROP SL; KLINTMALM GB; JENKINS R; PICKER LJ
      IMMUNE RECONSTITUTION WITH DONOR-DERIVED MEMORY EFFECTOR T-CELLS AFTER ORTHOTOPIC LIVER-TRANSPLANTATION/

      Experimental hematology
    12. COLLINS RH
      AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION

      Lancet
    13. BROWN RA; WOLFF SN; FAY JW; PINEIRO L; COLLINS RH; LYNCH JP; STEVENS D; GREER J; HERZIG RH; HERZIG GP
      HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION WITHALLOGENEIC BONE-MARROW TRANSPLANTATION FOR RESISTANT ACUTE MYELOID-LEUKEMIA - A STUDY BY THE NORTH-AMERICAN MARROW TRANSPLANT GROUP

      Leukemia & lymphoma
    14. STONE MJ; SAUSVILLE EA; FAY JW; HEADLEE D; COLLINS RH; FIGG WD; STETLERSTEVENSON M; JAIN V; JAFFE ES; SOLOMON D; LUSH RM; SENDEROWICZ A; GHETIE V; SCHINDLER J; UHR JW; VITETTA ES
      A PHASE-I STUDY OF BOLUS VERSUS CONTINUOUS-INFUSION OF THE ANTI-CD19 IMMUNOTOXIN, IGG-HD37-DGA, IN PATIENTS WITH B-CELL LYMPHOMA

      Blood
    15. COLLINS RH; SACKLER M; PITCHER CJ; WALDROP SL; KLINTMALM GB; JENKINS R; PICKER LJ
      IMMUNE RECONSTITUTION WITH DONOR-DERIVED MEMORY EFFECTOR T-CELLS AFTER ORTHOTOPIC LIVER-TRANSPLANTATION/

      Blood
    16. ARROWSMITH ER; GOODMAN SA; COLLINS RH; WOOD S; GREER JP; EDWARDS J; STEIN RS; BRANDT SA; PINEIRO LA; STEIN B; KALLIANPUR A; FAY JW; WOLFF SN
      MIS-MATCHED (MM) RELATED ALLOGENEIC (ALLO) BONE-MARROW TRANSPLANTATION (BMT) - ANALYSIS OF PROGNOSTIC FACTORS AND LONG-TERM SURVIVAL (LTS)

      Blood
    17. FAY JW; WINGARD JR; ANTIN JH; COLLINS RH; PINEIRO LA; BLAZAR BR; SARAL R; BIERER BE; PRZEPIORKA D; FITZSIMMONS WE; MAHER RM; WEISDORF DJ
      FK506 (TACROLIMUS) MONOTHERAPY FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER HISTOCOMPATIBLE SIBLING ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Blood
    18. COLLINS RH; KLINTMALM GB
      APLASTIC-ANEMIA AFTER LIVER-TRANSPLANTATION

      Hepatology
    19. ROSS AA; MILLER GW; MOSS TJ; KAHN DG; WARNER NE; SWEET DL; LOUIE KG; SCHNEIDERMANN E; PECORA AL; MEAGHER RC; HERZIG RH; COLLINS RH; FAY JW
      IMMUNOCYTOCHEMICAL DETECTION OF TUMOR-CELLS IN BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL COLLECTIONS FROM PATIENTS WITH OVARIAN-CANCER

      Bone marrow transplantation
    20. FAY JW; NASH RA; WINGARD JR; PRZEPIORKA D; COLLINS RH; ANASETTI C; DEVINE SM; PINEIRO LA; STORB RF; ARO RM; FITZSIMMONS WE
      FK 506-BASED IMMUNOSUPPRESSION FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER UNRELATED DONOR MARROW TRANSPLANTATION

      Transplantation proceedings
    21. COLLINS RH; PINEIRO LA; NEMUNAITIS JJ; JAIN VK; WAXMAN D; MILLER WV; FAY JW
      TRANSFUSION OF DONOR BUFFY COAT CELLS IN THE TREATMENT OF PERSISTENT OR RECURRENT MALIGNANCY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Transfusion
    22. BROWN RA; WOLFF SN; FAY JW; PINEIRO L; COLLINS RH; LYNCH JP; STEVENS D; GREER J; HERZIG RH; HERZIG GP
      HIGH-DOSE ETOPOSIDE, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN UNTREATED FIRST RELAPSE - A STUDY BY THE NORTH-AMERICANMARROW TRANSPLANT GROUP

      Blood
    23. COLLINS RH
      CD34(+) SELECTED CELLS IN CLINICAL TRANSPLANTATION

      Stem cells
    24. NIKAEIN A; POOLE T; FISHBECK R; ORDONEZ G; DOMBRAUSKY L; STONE MJ; COLLINS RH; FAY JW
      CHARACTERIZATION OF SKIN-INFILTRATING CELLS DURING ACUTE GRAFT-VERSUS-HOST DISEASE FOLLOWING BONE-MARROW TRANSPLANTATION USING UNRELATED MARROW DONORS

      Human immunology
    25. COLLINS RH
      TACROLIMUS (FK506) VERSUS CYCLOSPORINE IN PREVENTION OF LIVER ALLOGRAFT-REJECTION

      Lancet
    26. NIKAEIN A; COLLINS RH; KLINTMALM G; POOLE T; FAY JW; STONE MJ
      IMMUNOLOGICAL MONITORING OF GRAFT-VERSUS-HOST DISEASE FOLLOWING ORTHOTOPIC LIVER-TRANSPLANTATION

      Transplantation
    27. COLLINS RH; FAY JW
      TREATMENT OF LEUKEMIA IN RELAPSE AFTER BONE-MARROW TRANSPLANTATION

      The New England journal of medicine
    28. FAY JW; LAZARUS H; HERZIG R; SAEZ R; STEVENS DA; COLLINS RH; PINEIRO LA; COOPER BW; DICESARE J; CAMPION M; FELSER JM; HERZIG G; BERNSTEIN SH
      SEQUENTIAL ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-3 AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR MALIGNANT-LYMPHOMA - A PHASE I II MULTICENTER STUDY/

      Blood
    29. FAY JW; PINEIRO L; COLLINS RH; STEIN B; ARO RM; FITZSIMMONS WE
      FK506-BASED IMMUNOSUPPRESSION FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER UNRELATED MARROW DONOR (UMD) TRANSPLANTATION

      Blood
    30. FAY JW; FELSER J; LAZARUS HM; HERZIG R; SAEZ R; STEVENS D; COLLINS RH; PINERO L; COOPER B; HERZIG GP; CAMPION M; DICESARE J; BERNSTEIN SH
      SEQUENTIAL ADMINISTRATION OF INTERLEUKIN-3 (RHIL-3) AND RHGM-CSF FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION - AN UPDATE OF THE PHASE-I II TRIAL/

      Blood
    31. FAY JW; COLLINS RH; PINEIRO LA; NEMUNAITIS JJ; ARO R; FITZSIMMONS W
      FK506 TO PREVENT GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC MARROW TRANSPLANTATION (AMT) USING UNRELATED MARROW DONORS (UMD)-A PHASE-II STUDY

      Blood
    32. WOLFF SN; FAY JW; HERZIG RH; GREER JP; DUMMER S; BROWN RA; COLLINS RH; STEVENS DA; HERZIG GP
      HIGH-DOSE WEEKLY INTRAVENOUS IMMUNOGLOBULIN TO PREVENT INFECTIONS IN PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION OR SEVERE MYELOSUPPRESSIVE THERAPY - A STUDY OF THE AMERICAN-BONE-MARROW-TRANSPLANT-GROUP

      Annals of internal medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/10/20 alle ore 10:30:17